Sanara Medtech Stock Investor Sentiment

SMTI Stock  USD 31.05  0.85  2.66%   
Under 55% of Sanara Medtech's investor base is interested to short. The analysis of overall sentiment of trading Sanara Medtech stock suggests that many investors are impartial at this time. Sanara Medtech's investing sentiment shows overall attitude of investors towards Sanara Medtech.
  

Sanara Medtech Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Sanara Medtech can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over a year ago at simplywall.st         
Individual investors who hold 32 percent of Sanara MedTech Inc. gained 14, insiders profited as well
Simply Wall St News at Macroaxis
over a year ago at news.google.com         
Sanara MedTech Earns Overweight Rating from Cantor Fitzgerald - MarketBeat
Google News at Macroaxis
over a year ago at news.google.com         
Trading Advice - Stock Traders Daily
Google News at Macroaxis
over a year ago at news.google.com         
Trading With Integrated Risk Controls - Stock Traders Daily
Google News at Macroaxis
over a year ago at news.google.com         
Investment Analysis and Advice - Stock Traders Daily
Google News at Macroaxis
over a year ago at finance.yahoo.com         
Sanara MedTech Inc. About To Shift From Loss To Profit
Yahoo News
over a year ago at finance.yahoo.com         
Sanara MedTech Inc. Announces Exclusive License Agreement for Patented Collagen Peptides
Yahoo News
over a year ago at news.google.com         
Long Term Investment Analysis - Stock Traders Daily
Google News at Macroaxis
over a year ago at simplywall.st         
The 11 percent return this week takes Sanara MedTechs shareholders five-year gains to 997
Simply Wall St News at Macroaxis
over a year ago at news.google.com         
Sanara MedTech Inc.s top owners are retail ... - Yahoo Finance
Google News at Macroaxis
over a year ago at finance.yahoo.com         
Sanara MedTech Inc.s top owners are retail investors with 32 percent stake, while 31 percent is held...
Yahoo News
over a year ago at finance.yahoo.com         
Sanara MedTech Inc. Announces the Publication of a 5,335 Patient Study Demonstrating a Significant R...
Yahoo News
over a year ago at thelincolnianonline.com         
Sanara MedTech Inc. Forecasted to Post FY2023 Earnings of Per Share
news
over a year ago at thelincolnianonline.com         
Cantor Fitzgerald Trims Sanara MedTech Target Price to 49.00
news
over a year ago at news.google.com         
Sanara MedTech Third Quarter 2023 Earnings US0.13 loss per share - Simply Wall St
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Sanara Medtech that are available to investors today. That information is available publicly through Sanara media outlets and privately through word of mouth or via Sanara internal channels. However, regardless of the origin, that massive amount of Sanara data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Sanara Medtech news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Sanara Medtech relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Sanara Medtech's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Sanara Medtech alpha.

Sanara Medtech Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Long Term Trading Analysis for - Stock Traders Daily
12/17/2024
2
Insider Trading
01/15/2025
3
Sanara MedTech Inc. Announces Exclusive License and Distribution Agreement with, and Minority Investment in, Biomimetic Innovations Ltd
01/21/2025
4
Insiders were the key beneficiaries as Sanara MedTech Inc.s market cap rises to US297m - Simply Wall St
01/23/2025
5
Biomimetic Innovations Ltd, an affiliate of PBC Biomed, Announces an Exclusive License and Distribution Agreement and Minority Investment with Sanara MedTech In...
01/24/2025
6
Head-To-Head Survey Sanara MedTech vs. ReWalk Robotics
01/29/2025
7
Cantor Fitzgerald lifts Sanara MedTech target to 46, retains Overweight - MSN
02/14/2025
8
Acquisition by Jacob Waldrop of 8790 shares of Sanara Medtech subject to Rule 16b-3
02/25/2025
9
Investors in Sanara MedTech have seen strong returns of 215 percent over the past five years
03/03/2025
10
Disposition of 253 shares by Michael McNeil of Sanara Medtech at 22.97 subject to Rule 16b-3
03/05/2025
11
Sanara MedTech to Report Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025
03/11/2025
12
Acquisition by Michael McNeil of 6547 shares of Sanara Medtech subject to Rule 16b-3
03/13/2025

Complementary Tools for Sanara Stock analysis

When running Sanara Medtech's price analysis, check to measure Sanara Medtech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sanara Medtech is operating at the current time. Most of Sanara Medtech's value examination focuses on studying past and present price action to predict the probability of Sanara Medtech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sanara Medtech's price. Additionally, you may evaluate how the addition of Sanara Medtech to your portfolios can decrease your overall portfolio volatility.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Global Correlations
Find global opportunities by holding instruments from different markets
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets